Akaza

CATT Research Group

Chan

Chul Gu Kim

Dong Won Lee

Gomi

Han Joo Cho

Hirami

Ji Seon Baek

Jong Woo Kim

Kokame

Kuroiwa

Lantry

Matsuoka

Mordenti

Okubo

Shahar

Spaide

Tong

Yannuzzi

English

PubMed

Crossref

Korean Journal of Ophthalmology

Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy

a mAb against VEGF-A for the potential treatment of age-related macular degeneration and other ocular complications. Curr Opin Mol Ther

Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.

Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study.

Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration. Toxicol Pathol

Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results.

Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.

Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).

Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy.

Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.

Idiopathic polypoidal choroidal vasculopathy (IPCV).

Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.

One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.

Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Experiment Ophthalmol 2004;32:297-

Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Polypoidal choroidal vasculopathy and treatments.

Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics.

Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.

Role of photodynamic therapy in polypoidal choroidal vasculopathy.

The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3364425

Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy

Abstract

Similar works

Full text

Available Versions

Crossref